01-18-2012 04:34 PM CET - Health & Medicine
Print PDF Email

Endoscopy will become one of the fastest growing sectors in the medical device industry

Press release from: visiongain
pharmaceutical, contract, drugs, Pharma Market
pharmaceutical, contract, drugs, Pharma Market
A new report by visiongain, a London-based business information provider, predicts that the global market for endoscopy devices will be worth $75.8bn by 2022. The market generated sales of 23.3 billion dollars in 2010.

The medical device industry has experienced substantial growth in the past decade owing primarily to changes in patient demographics. A key factor in the growth of this market is endoscopy, which has progressed rapidly in recent years owing primarily to an increased patient demand for minimally invasive procedures for treatment and diagnosis purposes. Historically, endoscopy was regarded as a diagnostic procedure usually scheduled after the patient has undergone imaging scans, such as X-ray or MRI to determine the cause of their medical complaint. However, technological advancements in the field and broader applications of use in recent years has propelled the field of endoscopy, with new and innovative devices offering enhanced image quality and access to regions of the body previously thought as “difficult”. Physicians now regard endoscopy as the primary method of diagnoses and treatment, and will usually schedule this procedure ahead of an imaging scan.

Hemant Mistry, healthcare industry analyst, says: “A worldwide aging population is triggering a rise in the incidence of age related disorders such as arthritis and cancer. In response there has been a surge in patient demand for minimally invasive procedures such as laparoscopic surgery. Also, the aging population is causing an increase in reported cases of colorectal cancer. Early screening procedures, such as a colonoscopy or a capsule endoscopy, can reduce the mortality rate by up to 90%. An increased patient awareness of this preventative screening method will drive the demand for gastrointestinal endoscopic procedures.”

Visiongain’s research also suggests that the world endoscopy devices market may benefit from globalisation. Rapidly growing economies in countries such as Brazil, Russia, India and China (BRIC nations) is fuelling a rise in the middle class population with increased wealth. This will lead to an increased adoption of westernised lifestyles, most notably with regards to diet, prompting a rise in the incidence of conditions such as obesity and cardiovascular disease. Consequently, the number of reported laparoscopic weight-loss procedures will also increase. Furthermore, the rapid growth of these countries’ economies is also prompting a rise in healthcare spending and medical insurance cover.

Visiongain predicts that the endoscopy devices market will grow rapidly to 2022. The future of the endoscopy devices market appears promising and has significant potential for growth and investment with the increasing demand for safer, less invasive therapies. This new report adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.

For sample pages and further information concerning the Visiongain report Endoscopy devices: world market outlook 2012-2022 please visit www.visiongain.com/Report/744/Endoscopy-Devices-World-Mar...

For an executive summary of this report please email:
Sara Peerun at sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100


Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest growing and most innovative independent business intelligence companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters and management reports focusing on the Energy, Telecoms, Pharmaceuticals, Defence, Aviation and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Visiongain Ltd
230 City Road
London
EC1V 2QY
United Kingdom

This release was published on openPR.
News-ID: 207490
del.icio.us:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine MisterWong:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine Digg:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine StumbleUpon:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine Technorati:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine Reddit:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine Furl:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine WebNews:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine OneView:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine LinkArena:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine YiGG:Endoscopy will become one of the fastest growing sectors in the medical device industry - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.